HLA-B*57:01 typing in a Malaysian cohort: implications of abacavir hypersensitivity in people living with HIV

Author:

Kalidasan V1ORCID,Kunalan Iswarya12,Rajasuriar Reena34ORCID,Subbiah Vijay Kumar5ORCID,Das Kumitaa Theva1ORCID

Affiliation:

1. Department of Biomedical Sciences, Advanced Medical and Dental Institute, Universiti Sains Malaysia, 13200, Kepala Batas, Penang, Malaysia

2. School of Biological Sciences, Universiti Sains Malaysia, 11700, Gelugor, Penang, Malaysia

3. Department of Medicine, Faculty of Medicine, Universiti Malaya, 50603, Kuala Lumpur, Malaysia

4. Centre of Excellence Research in AIDS (CERiA), Faculty of Medicine, Universiti Malaya, 50603, Kuala Lumpur, Malaysia

5. Biotechnology Research Institute, Universiti Malaysia Sabah, 88400, Kota Kinabalu, Sabah, Malaysia

Abstract

Background: Abacavir (ABC) in combination with other antiretroviral drugs, is used to treat people living with HIV (PLWH). However, it is linked to a fatal hypersensitivity reaction in susceptible individuals, and is strongly associated with the HLA-B*57:01 allele. Materials & methods: A total of 152 patients, 50 PLWH and 102 HIV-1 negative patients, were assessed for the HLA-B*57:01 allele through a sequence-specific primer PCR. Results: All PLWH tested negative for the HLA-B*57:01 allele, but two HIV-negative patients were found to have HLA-B*57, with one of them expressing the HLA-B*57:01 allele. Conclusion: Given the low prevalence of this risk allele in the population, testing for the presence of HLA-B*57:01 in PLWH may not provide significant benefit for the reported population.

Funder

Universiti Sains Malaysia

Ministry of Higher Education, Malaysia

Publisher

Future Medicine Ltd

Subject

Pharmacology,Genetics,Molecular Medicine

Reference45 articles.

1. UNAIDS. Global HIV statistics (2022). www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf

2. Ministry of Health of Malaysia. Global AIDS monitoring. 2022, 1–44 (2022). https://www.moh.gov.my/moh/resources/Penerbitan/Laporan/Umum/MYS_country_report_2021.pdf

3. Antiretroviral drugs: Critical issues and recent advances

4. Abacavir

5. The abacavir hypersensitivity reaction: A review

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3